Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Germany, Netherlands, Switzerland, Spain, India, Australia, Sweden, Canada, Japan, Brazil, Austria, South Korea, Denmark, Poland, China, Italy, Portugal and Belgium registers with AO Innovation Translation Center as lead sponsor.Synced 10 Nov 2026
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Synced · Editorial standards
At a glance
AO Innovation Translation Center is the lead sponsor of 12 current clinical trials
in our Germany, Netherlands, Switzerland, Spain, India, Australia, Sweden, Canada, Japan, Brazil, Austria, South Korea, Denmark, Poland, China, Italy, Portugal and Belgium registers.
7 are recruiting patients now. The most common phase is Observational. The most-studied condition is Limb Fracture.
ClinicalTrials.gov trials by status
Recruiting758%
Not yet open18%
Active, closed433%
Trials by phase
Observational1192%
Not applicable18%
01
Clinical trials sponsored by AO Innovation Translation Center
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
02
Conditions in AO Innovation Translation Center trials
24 conditions
Limb Fracture1Bone Loss1Temporomandibular Joint Disorders1Long Bone Fractures1Spinal Column Tumor1Mandibular Reconstruction1Segmental Mandibular Defects1Orbital Fractures1Blow Out Fracture of Orbit1Periprosthetic Fractures1Periprosthetic Fracture Around Prosthetic Joint Implant1Clavicle1Acromioclavicular Joint1Fracture1Pelvic Fracture1Hip Fractures1Tibial Fractures1Ankle Fractures1Humeral Fracture, Proximal1Femoral Fracture1Spine Degeneration1Spine Disorder1Spine Pain1Spine Fusion1
A trial with sites in more than one country appears in each of those registers.
04
Questions about AO Innovation Translation Center trials
How many clinical trials does AO Innovation Translation Center sponsor?
AO Innovation Translation Center is the lead sponsor of 12 current trials on ClinicalTrials.gov in our Germany, Netherlands, Switzerland, Spain, India, Australia, Sweden, Canada, Japan, Brazil, Austria, South Korea, Denmark, Poland, China, Italy, Portugal and Belgium registers, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are AO Innovation Translation Center trials recruiting?
Yes. 7 of its 12 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.
Please verify before you rely on this.
This page is general information for life-science and pharmaceutical professionals. It is
not medical advice, and it has not been reviewed by a clinician — our editorial
team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most
recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC)
and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not
automatically interchangeable, and approvals, brand names and indications differ between the US, the
EU/Ireland (EMA/HPRA) and other regions.
Spotted an error? Tell us — we correct promptly and log it.
We value your privacy
With your consent, we use analytics cookies (Google Analytics and Microsoft Clarity) to understand how the site is used and improve it. We do not show advertising. You can change your choice at any time.
